{"name":"CeleCor Therapeutics","slug":"celecor-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdzlKZHhYZlI4TkMxazJ2N3JPd3FDb0VBbHJkeHotTFdkTUhLcGJ6ZmVBbjUxN0U3S3l1aXpIaVVuY0QtRFlIRmtOOGdBWFlpemlRTW9wQXlFVF9CWlZGSHlvNzROdEJ0Y2c0anRBVjE1Zkg3b1pocWs1NTNNOElpSmwxeHJkWUZuNTdIaHhqWGJMY3owak81RF9B?oc=5","date":"2026-03-24","type":"pipeline","source":"openPR.com","summary":"Acute Coronary Syndrome Market Size in the 7MM was ~USD 2.6 - openPR.com","headline":"Acute Coronary Syndrome Market Size in the 7MM was ~USD 2.6","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxOSHZoVG9KTk1PeDhha3F6eXZLalN1bmFZMy1wX2tPRm5NYWJ2aVQ3RE5zMGFvWnpiaGNqNDdsUXFtODN3SmE1THROdU5PV0FJN3ZFZGVzeHdXRDZSZzRfX2tZcXhHZHVaS0paZkFxLVJJaXdCeXpDU1E4cGV4eGYwVFJ1cFBIX3E5T0YtRElZNF9GZTBWY25RX0hSSEw0Y25DUllCRVJQTjNNRGtLMTV6amFWNTJvcTJDRExiZnJCbks2bTBlLU5UOHI3N0MzanJuenlUa3l4S2FOOTJWazVsWVNOeVpsOWU0X3V0LWRzNFdJUTlLcUhNdTNtb2QtVnFjZExMXzdJZVpxUkM3VXFLc3lKX1hVY0l1V1lZZjcxUXg5XzhDcGliN0EyWUloTGpma1ZzSFB4cU9HTmJnRXlNMFZn?oc=5","date":"2026-03-02","type":"pipeline","source":"GlobeNewswire","summary":"Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight - GlobeNewswire","headline":"Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNYzZ3OGVOX3pEZ0pSOUF6eGdoYm96M2RycEh0WUZxR0FuZHZQZDItSExsOVA4bEx2VzBmRVR2dENWX0Nod1laQXVSTjBSNzYzVGhCeTVVb0hlaVpKMkZ5eVA0WV9FVGtPSVBnbjc1Sm0wajVCSlNqZWhvbEVvQmJreldjMDhaU3cxbVBJWXdIUTM1Z0JqUnFHanE5bEhUUnpvMXpWVFlKSDV2MlhK?oc=5","date":"2025-12-12","type":"regulatory","source":"San Diego Business Journal","summary":"CeleCor Nearing Regulatory Approval of Heart Attack Drug - San Diego Business Journal","headline":"CeleCor Nearing Regulatory Approval of Heart Attack Drug","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-11-13","type":"trial","source":"Newswise","summary":"Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials | Newswise - Newswise","headline":"Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTTFvNzJqZHJVbHA5Sk5RVWRQQ1pUZmlYaUhMaDBhTHcyVERBMWxkN2pWZUV6R3R1NzBvZ1ZneG96a0ptandPSzROMlNJUVltcm9CbERHbFFBaVVqa0VjQUhKTFMyeDB5a3cxQ3BETHdnUDNjY0p1c01Ub1liVTZKWi1ZOU5HLUJrM3VQWEdULTBWVDdhdkx3cTFjX3ZRVWVCa1VoYnpZOTIycW8?oc=5","date":"2025-11-11","type":"regulatory","source":"Fierce Biotech","summary":"CeleCor Therapeutics tees up FDA filing with phase 3 win for rapid heart attack treatment - Fierce Biotech","headline":"CeleCor Therapeutics tees up FDA filing with phase 3 win for rapid heart attack treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxONVNKRkUycDZkUHVNNFZIWkhRb2VDSGJ3T0JjLVFNa3MtTy1zbWxUTTBDSVd1SVhob1M4Y1g4eUhiT0dWZnBkQ1MtMzNEa2o5cEVHSDhKZFFYdy1JXzFDMWxOTC1QN1dQOHIzSlM0bnU4N25lWDVwM1dqLTM4RFVrMG5kTFNUZjIzOGFIeDhaMmdiNUVlNzhfQWNxbjFKRFVNNS13MWlrb2JPV2pkQXJRR1ZYTXhlX3c5WnVxMDJTcTBDM28xN0tsU2ZTdDJ6S1U1QjFVTkFZUVNVUF9yVklYSg?oc=5","date":"2025-09-23","type":"trial","source":"prnewswire.com","summary":"PHASE 3 STUDY OF NOVEL ANTI-PLATELET DRUG FOR HEART ATTACK REPORTS POSITIVE TOPLINE RESULTS - prnewswire.com","headline":"PHASE 3 STUDY OF NOVEL ANTI-PLATELET DRUG FOR HEART ATTACK REPORTS POSITIVE TOPLINE RESULTS","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNNzZUbWZwXzZTS00xTmZ2aHF3SjVWZDljQ3hORGVza3BYa3VOWTBkUlk3aFdZMUJvUVBySF9Fb1FYWjZDRXl0aVZwNm1oUkdnYkhGX3J6RzlweHhualZCaVZHeGt0eHI3UU1ON2RHaWxDcndVaExmUEFKWkdtVmw3Y21WQ0lONWpXSF9CdFBIRUpRS3lIVXE3ZHlIN3E2WmtyRzhkRW5aWnB5VXRnTW9J?oc=5","date":"2025-05-28","type":"trial","source":"dicardiology.com","summary":"CeleCor Completes Phase 3 Clinical Trial of Anti-Platelet Agent for Heart Attack - dicardiology.com","headline":"CeleCor Completes Phase 3 Clinical Trial of Anti-Platelet Agent for Heart Attack","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQTGNjSHNvSG43RDVXd2V2bWt1MWM0cnFuTmV0bW45US1yb2R6c1d5OVZtWmRVODgxV2Q1c25CMDFFaE5XOHJrem53NjhBRXBQMVpKU0psa2VqU0MzYnhSdFlhTkFzRjNaZDhFWjVDYTlGTzVCSnBjZks3b2FjQlUtOXRwZmJWTHZyMUFrSWVwVG5rOW9WVEtnYW8zel9iTE8xcE85NWpHdGRMdTFHSWpCOGhYdkZWZGhJanlyNHBhcUx3RWpQZTN1bWYwNzJGUzRGSmpHd2k4dHo0MzdvR1pZblBjNzBBTG5scVZxWldJUQ?oc=5","date":"2025-01-15","type":"pipeline","source":"prnewswire.com","summary":"Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight - prnewswire.com","headline":"Acute Coronary Syndrome Market to Showcase a Significant Growth at a CAGR of 7.7% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQTGVTYmh1Wm5OYjFnanRKYUtKbmJrUDI2QV91eGdvU1gyRGV2RlRjeGUyek9TekVKNlBrR25EeHZPSmR2bFktSXJMekw1WmlVWTNCbXRZNGRjekQtYmxUdEZNbkNiUm8tc0hRUFFWNmV6aTFoUWp3S2FqRU5WU21kSnNtb1Uyd0Z3LWwtN19FVl9qaUR2czJiZk85Qlg2cDBJRnpMaVBCaGFQd3dDZjNnb2VkLVRDT0hudjR5OXNSazk3ZFRXS0REZjZhRUR3bUM0MXBXMVVwaWtvVmFlaXVvVHlrVGNxYmZqTlVlOWhtSzBJOUpEdDF2Q0I0Z3RlcXJVc1J5T3lDY2J1Z2ozMWVCS0F3RE16cWdyUEsya0JreXpjZFE2TGl1amo2YlJWcElRdE5rWEdoZ1FNSmlyS3ZORA?oc=5","date":"2025-01-13","type":"trial","source":"GlobeNewswire","summary":"Myocardial Infarction Clinical Trial Pipeline Appears - GlobeNewswire","headline":"Myocardial Infarction Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOZHhaWjFXcWRTdEF5Ump4WFRyalpxWURFZ0Z4cHpXVDBFMkpUU1ROdThzT2RFTjE1bmdUWkJJTW92UnNZRDlWWkFzX1d4eFg2eHFoUm5Ydld6QVlneGx4MWEtWHFaRTRyRloxTFZGUmMyYlZhTTU0RUVjdERSNlF0RWFkcVBNeURVZEZsMUE3dFV3T1hKb2c?oc=5","date":"2024-02-29","type":"trial","source":"Clinical Trials Arena","summary":"Myocardial Infarction: Three drug trials to watch in 2024 - Clinical Trials Arena","headline":"Myocardial Infarction: Three drug trials to watch in 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPR2hxb0xNU1dkWmNGZjh1ZFpZZ2Y2c2Z5UUtMT0ZqYktDcURnRDFwd0IyeWRUUDBjQlI2Q2xQTVdjYlhnR0JaSzV6SEI0QnREbUl5MEpZOXQ2Z2l2Sko2Ym9pcjFoNkVLUEYzME5PU0ZYdXQtbUdFUkJGc0otamZ3b3VTMmQ4ZjhMMFF5dlRHTF9veXhI?oc=5","date":"2023-08-01","type":"pipeline","source":"openPR.com","summary":"Rheumatoid Arthritis Pipeline Assessment (2023) Covering - openPR.com","headline":"Rheumatoid Arthritis Pipeline Assessment (2023) Covering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxONEpZZFdXUnF6MlZwcElQc0JGQW4yazhfaGZ2a2oteVYwSTNCZDRmNHRMeUE2Mm1NOGRCaXJFYkU3UnlPSmVHR2FkSEVvckk1Nlp3QU1zOWpBbVNJN3haV3podjhfbkY1SnA4TzljaXJVWTR2LWdsSWlKNFQ5TXNmMzUxWkd5VmxMQjN4YVRyOHczUQ?oc=5","date":"2015-12-19","type":"deal","source":"dicardiology.com","summary":"Baxter International Acquires Prism Pharmaceuticals - dicardiology.com","headline":"Baxter International Acquires Prism Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}